Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT05433259
Other study ID # OK lens-Angio OCT
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date September 1, 2021
Est. completion date November 1, 2023

Study information

Verified date June 2022
Source Wenzhou Medical University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Subjects fit with VST or CRT type lens are reviewed 1 day to 2 year after first wearing the lens. Ocular examinations were performed, including slit-lamp biomicroscope, uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), corneal topography (Medmont E300W, Medmont Pty Ltd, Melbourne, Australia), corneal refractive power (autorefractometer, KR880, Topcon, JAPAN), corneal epithelial thickness (Optical Coherence Tomography, RTVue-XR), axial length using IOL-Master 700 (Carl Zeiss Meditec AG). To investigate corneal and retina changes caused by overnight OK lens.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 60
Est. completion date November 1, 2023
Est. primary completion date March 12, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 8 Years and older
Eligibility Inclusion Criteria: - Normal subjects without any history of ocular surgeries or diseases (except for refractive errors) or systemic diseases that might affect contact lens wearing. The spherical error between -1.0 and -5.0 D, cylindrical error of at most 2.0 D, and a corrected distance visual acuity of 20/20 or better. Exclusion Criteria: - Subjects who had previously worn contact lens, were also excluded

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Overnight orthokeratology
Subjects require to wear the lenses every night, with a recommended time of 6-8 hours.

Locations

Country Name City State
China Eye Hospital of Wenzhou Medical College Wenzhou Zhejiang

Sponsors (1)

Lead Sponsor Collaborator
Wenzhou Medical University

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary change of Corneal Epithelium All epithelial thickness and treatment zone area record by baseline and follow up examination. up to 1 day, 1 week,1 month
Secondary Axial length Axial length growth after lens wear up to 2 years
See also
  Status Clinical Trial Phase
Not yet recruiting NCT03859440 - Three-month Clinical Evaluation of DSiHy Daily Disposable Silicone Hydrogel Contact Lenses N/A
Completed NCT00940459 - Subjective and Conjunctival Response to Edge Design of Different Silicone Hydrogels N/A
Completed NCT02921087 - Connecting Contact Lenses and Digital Technology N/A
Completed NCT01192126 - A Study to Evaluate the Product Performance of a Daily Disposable Contact Lens N/A
Completed NCT00982046 - A Clinical Comparison of Three Contact Lens Care Systems and Their Effect on Contact Lenses N/A